Orca Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Orca Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-35,682	Closed	-$1.94M	–	57
2024 Q1	$1.94M	Sell	35,682 -1,718	-5%	-$87.5K	1.81%	21
2023 Q4	$1.92M	Sell	37,400 -908	-2%	-$47.7K	1.84%	18
2023 Q3	$2.22M	Sell	38,308 -695	-2%	-$42.6K	2.47%	12
2023 Q2	$2.49M	Sell	39,003 -575	-1%	-$38.6K	2.72%	11
2023 Q1	$2.74M	Sell	39,578 -325	-0.8%	-$22.9K	3.36%	6
2022 Q4	$2.87M	Sell	39,903 -1,988	-5%	-$150K	3.64%	7
2022 Q3	$2.98M	Hold	41,891	–	–	3.89%	5
2022 Q2	$3.23M	Buy	41,891 +162	+0.4%	+$12.3K	2.98%	7
2022 Q1	$3.05M	Buy	41,729 +50	+0.1%	+$3.36K	2.49%	10
2021 Q4	$2.6M	Sell	41,679 -314	-0.7%	-$18.4K	2.14%	14
2021 Q3	$2.48M	Buy	41,993 +176	+0.4%	+$11.6K	2.17%	13
2021 Q2	$2.79M	Sell	41,817 -240	-0.6%	-$15.6K	2.52%	10
2021 Q1	$2.65M	Sell	42,057 -485	-1%	-$30.2K	2.75%	9
2020 Q4	$2.64M	Buy	+42,542	New	+$2.62M	2.76%	7

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Orca Investment Management's BMY Position: Q2 2024 in Review

Orca Investment Management sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 35,682 shares — an estimated $1.94M sold.

Orca Investment Management first reported a position in BMY in Q4 2020 and held it in 14 quarters. The position peaked at $3.23M in Q2 2022. 2,152 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

Orca Investment Management reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
Orca Investment Management sold 35,682 Bristol-Myers Squibb shares in Q2 2024, an estimated $1.94M.
Orca Investment Management first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 14 quarters.
Orca Investment Management's Bristol-Myers Squibb position peaked at $3.23M in Q2 2022.
2,152 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Orca Investment Management's 13F filing for Q2 2024, filed 6 Aug 2024.